Cardiovascular Events After Bariatric Surgery in Obese Subjects With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Obese individuals with type 2 diabetes have an increased risk of cardiovascular disease. The effect of bariatric surgery on cardiovascular events in obese individuals with type 2 diabetes remains to be determined. The Swedish Obese Subjects (SOS) study is a prospective, controlled intervention study that examines the effects of bariatric surgery on hard end points. The aim of the present study was to examine the effect of bariatric surgery on cardiovascular events in the SOS study participants with type 2 diabetes. RESEARCH DESIGN AND METHODS: All SOS study participants with type 2 diabetes at baseline were included in the analyses (n = 345 in the surgery group and n = 262 in the control group). Mean follow-up was 13.3 years (interquartile range 10.2–16.4) for all cardiovascular events. RESULTS: Bariatric surgery was associated with a reduced myocardial infarction incidence (38 events among the 345 subjects in the surgery group vs. 43 events among the 262 subjects in the control group; log-rank P = 0.017; adjusted hazard ratio [HR] 0.56 [95% CI 0.34–0.93]; P = 0.025). No effect of bariatric surgery was observed on stroke incidence (34 events among the 345 subjects in the surgery group vs. 24 events among the 262 subjects in the control group; log-rank P = 0.852; adjusted HR 0.73 [0.41–1.30]; P = 0.29). The effect of surgery in reducing myocardial infarction incidence was stronger in individuals with higher serum total cholesterol and triglycerides at baseline (interaction P value = 0.02 for both traits). BMI (interaction P value = 0.12) was not related to the surgery outcome. CONCLUSIONS: Bariatric surgery reduces the incidence of myocardial infarction in obese individuals with type 2 diabetes. Preoperative BMI should be integrated with metabolic parameters to maximize the benefits of bariatric surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Cumulative incidence of cardiovascular events in SOS subjects with diabetes at baseline. A: There were 63 cardiovascular events (CVEs) among the 345 subjects in the surgery group (median follow-up = 13.9 years [10.7–16.9 years]), compared with 65 events among the 262 subjects in the control group (median follow up = 12.2 years [9.9–15.8 years]). CVEs: myocardial infarction and stroke combined, whichever came first. B: Among the 345 subjects in the surgery group, there were 38 myocardial infarctions (MIs), compared with 43 among the 262 subjects in the control group. C: Out of 345 subjects in the surgery group, 34 had stroke, compared with 24 of the 262 subjects in the control group.](https://figures.cochat.ai/paper-figures/0377c61c2ce5424995e79c62e689355d/cardiovascular-events-after-bariatric-surgery-in-obese-subjects-with-type-2-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The Swedish Obesity Subjects (SOS) study (ClinicalTrials.gov number NCT01479452) reported lower cardiovascular event rates over a mean follow-up of 13.3 years in patients with type 2 diabetes who underwent bariatric surgery;5”
From Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes (2013) · cites this paper as [5]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“loss of glucose-oxidative muscle mass (through inactivity or chronic inflammation) promotes type 2 diabetes at lower weights in older age”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [35]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“when a stable body weight probably reflects gain of adipose tissue. 35”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,780
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Self-citationLifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Self-citationStandards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 1×
“These data are in line with previous reports on the metabolic changes after bariatric surgery (5,9,18,19).”
ResultBariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656 · cited 4×
“Taken together, these results suggest that to maximize the benefits, metabolic parameters should be used to select obese patients for surgery (7,20).”
BackgroundInfluentialSelf-citationDixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Cited by
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Sjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835
Self-citationLow Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
“cardial infarction in obese individuals with type 2 diabetes mellitus.(359) Total mortality rates appear 30% to 40% lower in patients who have had bariatric surgery for obesity management(354,357) and may be more prominent in those with diabetes mellitus at the time of surgery,(360) although survival benefit effects m…”
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054
Self-citationBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552
“On Insulin therapy, n (%) 71 (33) 31 (14) 35 (16) <0.”
Bariatric surgery for obesity and metabolic conditions in adults
Arterburn, D. E., & Courcoulas, A. P. (2014) · BMJ · doi:10.1136/bmj.g3961 · Cited by 394
Long-term Outcomes of Bariatric Surgery: A National Institutes of Health Symposium
Courcoulas, A. P., Yanovski, S. Z., Bonds, D., Eggerman, T. L., Horlick, M., Staten, M. A., & Arterburn, D. E. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.2440 · Cited by 325
The importance of weight management in type 2 diabetes mellitus
Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314
Prediabetes and Cardiovascular Disease
Brannick, B., & Dagogo-Jack, S. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.001 · Cited by 293
Bariatric and metabolic surgery: a shift in eligibility and success criteria
Frühbeck, G. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.84 · Cited by 230
Towards a multidisciplinary approach to understand and manage obesity and related diseases
Bischoff, S. C., Boirie, Y., Cederholm, T., Chourdakis, M., Cuerda, C., Delzenne, N. M., Deutz, N. E., Fouque, D., Genton, L., Gil, C., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.11.007 · Cited by 206
“Although recurrence of T2DM is seen in up to 40% of patients in long-term follow up, glucose control is still improved and risk of macrovascular complications reduced compared to medical treated controls [225,226].”
BackgroundPrecision medicine in the management of type 2 diabetes
Gloyn, A. L., & Drucker, D. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30052-4 · Cited by 183
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Yu, J., Zhou, X., Li, L., Li, S., Tan, J., Li, Y., & Sun, X. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1460-2 · Cited by 178
“Evidence showed intensive glycemic control can reduce the incidence of diabetic complications [45, 46].”
BackgroundEliasson, B., Liakopoulos, V., Franzén, S., Näslund, I., Svensson, A.-M., Ottosson, J., & Gudbjörnsdottir, S. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00334-4 · Cited by 167
Adiposity as a cause of cardiovascular disease: a Mendelian randomization study
Hagg, S., Fall, T., Ploner, A., Magi, R., Fischer, K., Draisma, H. H., Kals, M., de Vries, P. S., Dehghan, A., Willems, S. M., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv094 · Cited by 142
“Randomized intervention trials of weight loss have been inconclusive.(9,10) However, it should be noted that atherosclerosis is driven by a long-term, low-grade inflammatory process, and short-term interventions on adiposity late in life might not reflect the same exposure as indicators of adiposity in MR studies.”
BackgroundResultJohnson, B. L., Blackhurst, D. W., Latham, B. B., Cull, D. L., Bour, E. S., Oliver, T. L., Williams, B., Taylor, S. M., & Scott, J. D. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.12.019 · Cited by 132
The gut microbiota as a mediator of metabolic benefits after bariatric surgery
Anhê, F. F., Varin, T. V., Schertzer, J. D., & Marette, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.02.002 · Cited by 93
Gregg, E. W., Chen, H., Bancks, M. P., Manalac, R., Maruthur, N., Munshi, M., Wing, R., & for the Look AHEAD Research Group (2024) · Diabetologia · doi:10.1007/s00125-023-06048-6 · Cited by 87
T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
Shirakawa, K., & Sano, M. (2021) · Cells · doi:10.3390/cells10092435 · Cited by 97
Sjöholm, K., Carlsson, L. M. S., Svensson, P.-A., Andersson-Assarsson, J. C., Kristensson, F., Jacobson, P., Peltonen, M., & Taube, M. (2022) · Diabetes Care · doi:10.2337/dc21-1335 · Cited by 84
Self-citationBeating type 2 diabetes into remission
McCombie, L., Leslie, W., Taylor, R., Kennon, B., Sattar, N., & Lean, M. E. J. (2017) · BMJ · doi:10.1136/bmj.j4030 · Cited by 81
Evaluation of Current Eligibility Criteria for Bariatric Surgery
Sjöholm, K., Anveden, Å., Peltonen, M., Jacobson, P., Romeo, S., Svensson, P.-A., Sjöström, L., & Carlsson, L. M. S. (2013) · Diabetes Care · doi:10.2337/dc12-1395 · Cited by 79
Self-citationEffects of Bariatric Surgery on Cancer Risk: Evidence from Meta-analysis
Zhang, K., Luo, Y., Dai, H., & Deng, Z. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04368-4 · Cited by 83
Maglio, C., Peltonen, M., Rudin, A., & Carlsson, L. M. S. (2017) · Obesity · doi:10.1002/oby.21955 · Cited by 67
“Bariatric surgery is the most effective way to achieve and maintain weight loss (20,23); it also reduces the risk and improves the prognosis of several obesity-associated disorders, such as type 2 diabetes and cardiovascular diseases (23-26).”
Self-citationSurgical Management of Obesity and the Relationship to Cardiovascular Disease
Vest, A. R., Heneghan, H. M., Schauer, P. R., & Young, J. B. (2013) · Circulation · doi:10.1161/circulationaha.112.103275 · Cited by 65
“Conversely, the mortality benefit offered by bariatric surgery was unrelated to age, sex, or BMI in the studies of Peeters et al(123) and Romeo et al.(125) There are also contradictions between the outcome studies in their implications as to which obese individuals hold the potential for the greater mortality benefit…”
BackgroundEeg‐Olofsson, K., Guðbjörnsdóttir, S., Eliasson, B., Zethelius, B., & Cederholm, J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.07.010 · Cited by 71
Biliopancreatic Diversion in Nonobese Patients With Type 2 Diabetes: Impact and Mechanisms
Astiarraga, B., Gastaldelli, A., Muscelli, E., Baldi, S., Camastra, S., Mari, A., Papadia, F., Camerini, G., Adami, G., Scopinaro, N., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1476 · Cited by 63
“at 12 months) than in remitters (20 [4] to 32 [interquartile”
BackgroundVisceral adiposopathy: a vascular perspective
Farb, M. G., & Gokce, N. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0047 · Cited by 79
“It is also the sole weight reduction method shown to reduce long-term ( > 10 year) cardiovascular mortality, largely owning to decreased myocardial infarction risk [100, 121, 122].”
Pharmacotherapy for obesity: moving towards efficacy improvement
Coutinho, W. F., & Halpern, B. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01233-4 · Cited by 70
“Currently, the most effective treatment for obesity is bariatric surgery; in prospective studies, individuals who underwent bariatric surgery had reduced mortality, myocardial infarction, and T2DM incidence [14, 17, 18].”
BackgroundPontiroli, A. E., Zakaria, A. S., Fanchini, M., Osio, C., Tagliabue, E., Micheletto, G., Saibene, A., & Folli, F. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0801-1 · Cited by 62
Miras, A. D., Kamocka, A., Patel, D. R., Dexter, S. P. L., Finlay, I. G., Hopkins, J. C. A., Khan, O. A., Reddy, M., Sedman, P. C., Small, P. K., et al. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.02.012 · Cited by 58
“, hypertension and dyslipidemia)—into reduction in the incidence of T2D-related micro- and macrovascular complications [5,16].”
BackgroundType 2 diabetes and cardiovascular disease: what next?
Joseph, J. J., & Golden, S. H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000044 · Cited by 57
“Bariatric surgery interventions SOS Substudy [23] A subset of 607 T2DM patients in SOS trial, 345 individuals in the surgery group and 262 individuals in the control group.”
BackgroundMethodPhysical activity and risk of cardiovascular disease by weight status among U.S adults
Zhang, X., Cash, R. E., Bower, J. K., Focht, B. C., & Paskett, E. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232893 · Cited by 67
Intensive lifestyle intervention in type 2 diabetes.
Wing, R. R., Reboussin, D., & Lewis, C. E. (2013) · PubMed · doi:10.1056/nejmc1312802 · Cited by 13
Effects of bariatric surgery on pericardial ectopic fat depositions and cardiovascular function
van Schinkel, L. D., Sleddering, M. A., Lips, M. A., Jonker, J. T., Roos, A., Lamb, H. J., Jazet, I. M., Pijl, H., & Smit, J. W. A. (2014) · Clinical Endocrinology · doi:10.1111/cen.12402 · Cited by 52
Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
Elliott, J. A., & Reynolds, J. V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.627270 · Cited by 51
Herder, C., Peltonen, M., Svensson, P., Carstensen, M., Jacobson, P., Roden, M., Sjöström, L., & Carlsson, L. M. S. (2014) · Diabetes Care · doi:10.2337/dc13-1362 · Cited by 49
Self-citationYan, G., Wang, J., Zhang, J., Gao, K., Zhao, Q., & Xu, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224828 · Cited by 53
“Recently published randomized controlled trials (RCTs) recommend bariatric surgery as the best treatment for obesity and T2DM [2].”
BackgroundInfluentialWharton, S., Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.025 · Cited by 54
Surgery in the treatment of type 2 diabetes mellitus
Maleckas, A., Venclauskas, L., Wallenius, V., Lönroth, H., & Fändriks, L. (2015) · Scandinavian Journal of Surgery · doi:10.1177/1457496914561140 · Cited by 48
“In SoS trial, significant 44% reduction in myocardial infarction incidence at 13 years was found in the subgroup of patients with T2DM (37).”
BackgroundMetabolic and Bariatric Surgery for Obesity
Vidal, J., Corcelles, R., Jiménez, A., Flores, L., & Lacy, A. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.051 · Cited by 45
‘Adiposopathy’ and cardiovascular disease: the benefits of bariatric surgery
Appachi, S., & Kashyap, S. R. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283642a33 · Cited by 45
Thirty‐Year Risk of Cardiovascular Disease Events in Adolescents with Severe Obesity
Ryder, J. R., Xu, P., Inge, T. H., Xie, C., Jenkins, T. M., Hur, C., Lee, M., Choi, J., Michalsky, M. P., Kelly, A. S., et al. (2020) · Obesity · doi:10.1002/oby.22725 · Cited by 43
“Data in adults undergoing MBS have demonstrated a significant reduction in CVD events and mortality compared with nonsurgical controls (21-23).”
BackgroundResultMiras, A. D., Kamocka, A., Pérez‐Pevida, B., Purkayastha, S., Moorthy, K., Patel, A. G., Chahal, H., Frost, G. S., Bassett, P., Castagneto‐Gissey, L., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0762 · Cited by 43
“(4,5), and improved quality of life (2,3).”
Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health
Miras, A. D., & le Roux, C. W. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70158-x · Cited by 40
Shakiba, M., Mansournia, M. A., Salari, A., Soori, H., Mansournia, N., & Kaufman, J. S. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx360 · Cited by 40
“The effect of obesity was also assessed through weight-loss strategies as an intervention in randomized trials or using the parametric G-formula in observational studies (39, 42, 43).”
Chandrakumar, H. P., Khatun, N., Gupta, T., Graham-Hill, S., Zhyvotovska, A., & McFarlane, S. I. (2023) · Cureus · doi:10.7759/cureus.34723 · Cited by 48
“…2020 [19] NA NA 0.98 (0.66-1.45) NA Ardissino et al., 2021 [20] 1/593 4/593 0.0227 (0.0009-5.45) NA Sjöström et al., 2007 [23] 6/2010 6/2037 NA NA Romeo et al., 2012 [24] NA NA 0.73 (0.41-1.30) NA Sjöström et al., 2012 [25] 93/2010 111/2037 0.66 (0.49-0.90) NA Johnson et al., 2013 [26] 11/2580…”
InfluentialEffect of Gastric Bypass Versus Diet on Cardiovascular Risk Factors
Raffaelli, M., Guidone, C., Callari, C., Iaconelli, A., Bellantone, R. D. A., & Mingrone, G. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31829d6989 · Cited by 38
Feingold, K. R., & Grünfeld, C. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_14 · Cited by 50
Billeter, A. T., Eichel, S., Scheurlen, K. M., Probst, P., Kopf, S., & Müller-Stich, B. P. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.04.029 · Cited by 34
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
Shirakawa, K., & Sano, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1044737 · Cited by 38
on behalf of the LAGB10 working group, Pontiroli, A. E., Zakaria, A. S., Mantegazza, E., Morabito, A., Saibene, A., Mozzi, E., & Micheletto, G. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0347-z · Cited by 37
Cardiovascular disease in diabetes type 2: current concepts
Rosengren, A. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12804 · Cited by 40
Shirakawa, K., Endo, J., Katsumata, Y., Yamamoto, T., Kataoka, M., Isobe, S., Yoshida, N., Fukuda, K., & Sano, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186303 · Cited by 37
The threshold shift paradigm of obesity: evidence from surgically induced weight loss
Ferrannini, E., Rosenbaum, M., & Leibel, R. L. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.090167 · Cited by 32
de Vries, T. I., Dorresteijn, J. A. N., van der Graaf, Y., Visseren, F. L. J., & Westerink, J. (2019) · Diabetes Care · doi:10.2337/dc19-0776 · Cited by 31
“Current smoking 32 (3) 29 (2) 45 (4) 102 (8) ,0.”
BackgroundCOHEN, R. V., Pereira, T., Aboud, C. M., Caravatto, P. P. D. P., Petry, T. B. Z., Correa, J. L., Schiavon, C. A., Correa, M., Pompílio, C. E., Pechy, F. N. Q., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013574 · Cited by 31
Ceriani, V., Sarro, G., Micheletto, G., Giovanelli, A., Zakaria, A. S., Fanchini, M., Osio, C., Nosari, I., Morabito, A., Pontiroli, A. E., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0244-5 · Cited by 28
Pontiroli, A. E., Ceriani, V., & Tagliabue, E. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04530-3 · Cited by 29
Diedisheim, M., Poitou, C., Genser, L., Amouyal, C., Bouillot, J., Ciangura, C., Oppert, J., Clément, K., & Aron‐Wisnewsky, J. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05075-1 · Cited by 28
Miras, A. D., Risstad, H., Baqai, N., Law, S., Søvik, T. T., Mala, T., Olbers, T., Kristinsson, J. A., & le Roux, C. W. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12177 · Cited by 26
“The number of bariatric procedures performed on patients with T2DM has increased dramatically in the last decade [8,9].”
BackgroundZakaria, A. S., Rossetti, L. M., Cristina, M., Veronelli, A. M., Lombardi, F., Saibene, A., Micheletto, G., & Pontiroli, A. E. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.10.062 · Cited by 24
“Finally, bariatric surgery prevents cardiovascular, all causes of noncardiovascular, and overall mortality in obese patients compared with medical treatment [11] in average patients and those with diabetes or with pre-existing cardiovascular disease [12–16].”
BackgroundMetabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist’ s perspective
Sonali, G., Hong, C., Phong, C., & Tham, K. W. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140127 · Cited by 26
“An extended follow-up of 16 years revealed decreased overall mortality in obese patients with type 2 diabetes who had undergone bariatric surgery [42,43] .”
BackgroundAlkharaiji, M. A., Anyanwagu, U., Donnelly, R., & IDRIS, I. R. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03809-4 · Cited by 22
Wong, C. K. H., Wu, T., Wong, S. K., Law, B. T. T., Grieve, E., Ng, E. K., Wu, O., & Lam, C. L. K. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa075 · Cited by 23
A Look Ahead at the Future of Diabetes Prevention and Treatment
Arterburn, D. E., & O’Connor, P. J. (2012) · JAMA · doi:10.1001/jama.2012.144749 · Cited by 22
Çelik, A., Ugale, S. M., Ofluoğlu, H., Vural, E., Çağıltay, E., Cat, H., Asci, M., & Celik, B. O. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1671-1 · Cited by 20
“On the other hand, surgical treatment has also been associated with reduced rates of cardiovascular events [7] and mortality [8, 9].”
BackgroundBilleter, A. T., Herrera, J. R. D. L. G., Scheurlen, K. M., Nickel, F., Billmann, F. G., & Müller-Stich, B. P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0009 · Cited by 20
Dicker, D., Greenland, P., Leibowitz, M., Hoshen, M., Senderey, A. B., Rasmussen‐Torvik, L. J., Balicer, R. D., & Reges, O. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05068-0 · Cited by 19
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
Khunti, K., Papamargaritis, D., Aroda, V. R., Anjana, R. M., & Kashyap, S. R. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00134-2 · Cited by 22
Burggraaf, B., & Cabezas, M. C. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.04.017 · Cited by 18
Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m2: A Surgeon’s Perspective
COHEN, R. V., Caravatto, P. P. D. P., & Petry, T. B. Z. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0930-2 · Cited by 17
“This multifactorial approach targeted all components of metabolic syndrome and was not only a glycemia-focused approach [2, 37, 91–93].”
BackgroundDisease Severity and Staging of Obesity: a Rational Approach to Patient Selection
Whyte, M., Velusamy, S., & Aylwin, S. J. B. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0456-7 · Cited by 18
Influenza, Pneumococcal, Hepatitis B and Herpes Zoster Vaccinations
Husein, N., & Chetty, A. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.016 · Cited by 15
The dual challenge of diabesity: pathophysiology, management, and future directions
Sindhwani, R., Bora, K. S., & Hazra, S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03713-4 · Cited by 21
“Smoking-induced vasoconstriction leads to impaired renal perfusion, while nicotine stimulates the renin-angiotensin-aldosterone system (RAAS), contributing to glomerular hypertension and hyperfiltration.”
InfluentialEstimating Effect of Obesity on Stroke Using G‐Estimation: The ARIC study
Shakiba, M., Mansournia, M. A., & Kaufman, J. S. (2019) · Obesity · doi:10.1002/oby.22365 · Cited by 16
“The methodology of previously published causal studies was either the use of an interventional trial for assessing the effect of weight loss or using instrumental variable analysis based on a Mendelian randomization approach for assessing BMI on risk of cardiovascular events (34-37).”
BackgroundMethodKenkre, J. S., Tan, T., & Bloom, S. R. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.5 · Cited by 17
Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents
Till, H., Mann, O., Singer, G., & Blüher, S. (2021) · Children · doi:10.3390/children8050372 · Cited by 14
Role of Bariatric Surgery in Diabetes
Poirier, P., & Auclair, A. (2014) · Current Cardiology Reports · doi:10.1007/s11886-013-0444-5 · Cited by 17
COHEN, R. V., Caravatto, P. P. D. P., Petry, T. B. Z., & Cummings, D. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0355-3 · Cited by 13
Time to Glycemic Control - an Observational Study of 3 Different Operations
Çelik, A., Pouwels, S., Karaca, F. C., Çağıltay, E., Ugale, S. M., Etikán, Í., Büyükbozkırlı, D., & Kılıç, Y. E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2344-4 · Cited by 13
“A growing body of literature shows that bariatric surgery achieves favorable metabolic outcomes, is associated with a reduction in cardiovascular events and mortality, and can provide effective treatment for T2DM in obese patients [6–16].”
BackgroundEickhoff, H., Rodrigues, T., Neves, I. J., Marques, D., Ribeiro, D. C., Costa, S., Seiça, R. M. F., & Matafome, P. N. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03935-z · Cited by 14
Diabetes and CVD Risk: Special Considerations in African Americans Related to Care
Wittwer, J. A., Golden, S. H., & Joseph, J. J. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-00648-2 · Cited by 14
Aktuelle Therapie des Typ-2-Diabetes
Schernthaner, G., & Schernthaner, G.-H. (2012) · Der Internist · doi:10.1007/s00108-012-3203-6 · Cited by 12
Çelik, A., Çağıltay, E., Ugale, S. M., Asci, M., Celik, B. O., Karaca, C. A., & Abdul‐Ghani, M. A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.09.027 · Cited by 12
“It is likely that this improvement may further contribute to the decreased cardiovascular disease risk associated with bariatric surgery [24,25].”
BackgroundGoldberg, I., Nie, L., Yang, J., Docimo, S., Obici, S., Talamini, M. A., Pryor, A. D., & Spaniolas, K. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07848-2 · Cited by 14
Liakopoulos, V., Franzén, S., Svensson, J., Zethelius, B., Ottosson, J., Näslund, I., Guðbjörnsdóttir, S., & Eliasson, B. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000386 · Cited by 11
Assumpção, R. P., Bahia, L., da Rosa, M. Q. M., Correia, M. G., da Silva, E. N., Zubiaurre, P. R., Mottin, C. C., & Vianna, D. A. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03957-7 · Cited by 13
Feingold, K. R. (2020) · Europe PMC (PubMed Central) · Cited by 11
Obeso-Fernández, J., Millán-Alanís, J. M., Sáenz-Flores, M., Rodríguez-Bautista, M., Medrano-Juárez, S., Oyervides-Fuentes, S., Gonzalez‐Cruz, D., Manzanares-Gallegos, D. M., González‐González, J. G., & Rodríguez-Gutiérrez, R. (2023) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2023.08.016 · Cited by 9
Broek, M., de Heide, L. J. M., Veeger, N. J. G. M., van der Wal-Oost, A. M., & Beek, V. A. (2016) · Obesity Facts · doi:10.1159/000446744 · Cited by 12
Obesity and increased risk of esophageal adenocarcinoma
Elliott, J. A., Donohoe, C. L., & Reynolds, J. V. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1077696 · Cited by 8
I Diretriz sobre Aspectos Específicos de Diabetes (tipo 2) Relacionados à Cardiologia
Gualandro, D., Azevedo, F., Calderaro, D., Marcondes‐Braga, F. G., Caramelli, B., Schaan, B. D., Soeiro, A., Mansur, A. D. P., Rochitte, C. E., Junior, C. V. S., et al. (2014) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2014s002 · Cited by 17
Bariatric surgery as a treatment option in patients with type 2 diabetes mellitus
Spanou, M., & Tziomalos, K. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i2.14 · Cited by 8
Benenati, N., Bufano, A., Cantara, S., Ricci, C., Marzocchi, C., Ciuoli, C., Sannino, I., Tirone, A., Voglino, C., Vuolo, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14863-x · Cited by 8
Cardiorenal outcomes in eligible patients referred for bariatric surgery
Dash, S., Everett, K., Jackson, T. D., Okrainec, A., Urbach, D. R., Sockalingam, S., Shah, B. R., & Farkouh, M. E. (2021) · Obesity · doi:10.1002/oby.23294 · Cited by 7
Lipidomic Profiling at the Interface of Metabolic Surgery and Cardiovascular Disease
Ban, R. H., Kamvissi, V., Schulte, K., Bornstein, S. R., Rubino, F., & Graessler, J. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0455-8 · Cited by 8
Pereira, P., Guimarães, M., Morais, T., Pereira, S. S., Nora, M. C., & Monteiro, M. P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00718 · Cited by 7
“Furthermore, weight loss elicited by bariatric surgery was proven to be particularly effective in decreasing the CV risk, as well as preventing CV events and mortality in individuals with high insulin and/or glucose levels at baseline (13, 23).”
BackgroundMethodResult
Metadata
- Authors
- Romeo, S., Maglio, C., Burza, M. A., Pirazzi, C., Sjöholm, K., Jacobson, P., Svensson, P.-A., Peltonen, M., Sjöström, L., & Carlsson, L. M. S.
- Affiliations
- University of Gothenburg (SE)
- Finnish Institute for Health and Welfare (FI)
- Corresponding author
- Romeo, Stefano
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2613-2617
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3507566
- OpenAlex
- W2033058666
- Cited by
- 172
- References
- 20
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 3 · 2021: 8 · 2020: 18 · 2019: 10 · 2018: 14 · 2017: 15 · 2016: 13 · 2015: 19 · 2014: 25 · 2013: 24 · 2012: 3
- FWCI
- 23.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- WOS
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- bariatric surgery, type 2 diabetes, obesity, cardiovascular events, myocardial infarction, stroke, Swedish Obese Subjects study, serum cholesterol, triglycerides, long-term outcomes
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Myocardial Infarction, Obesity, Stroke, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.